UTHR - Company ID 0001082554
The table below shows UNITED THERAPEUTICS Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.56B | $1.70B | $1.21B | $961.20M | $894.80M | $738.70M |
| Short-term investments | $1.36B | $1.57B | $1.79B | $1.88B | $1.04B | $1.10B |
| Receivables | $350.20M | $279.30M | $278.90M | $220.40M | $198.70M | $157.40M |
| Inventory | $183.10M | $157.90M | $111.80M | $102.00M | $93.80M | $86.50M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $3.70B |
| $3.87B |
| $3.55B |
| $3.38B |
| $2.32B |
| $2.17B |
| Property, plant & equipment | $1.73B | $1.22B | $1.05B | $861.50M | $780.90M | $731.60M |
| Goodwill | $32.30M | $32.30M | $33.70M | $28.00M | $28.00M | $28.00M |
| Total assets | $7.88B | $7.36B | $7.17B | $6.04B | $5.17B | $4.62B |
| Accounts payable | $7.10M | $6.00M | $5.60M | $4.10M | $3.80M | $4.10M |
| Total current liabilities | $560.60M | $738.10M | $804.40M | $343.20M | $305.40M | $323.30M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $783.80M | $920.00M | $1.18B | $1.25B | $1.21B | $1.22B |
| Retained earnings | $8.56B | $7.22B | $6.03B | $5.04B | $4.32B | $3.84B |
| Total equity | $7.10B | $6.44B | $5.98B | $4.80B | $3.96B | $3.40B |